Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Method for immunologically assaying hemoglobin A1c in specimen

A technology of hemoglobin and immunoassay, applied in the field of immunoassay of hemoglobin A1c, which can solve the problems of unable to collect red blood cells, red blood cell sedimentation, keeping a respectful distance, etc., achieve the effect of suppressing the amount of medical waste, suppressing the cost of implementation, and improving the sample processing capacity

Inactive Publication Date: 2015-12-02
FUJIREBIO CO LTD
View PDF5 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] However, in fact, there are also equipment that cannot perform pretreatment such as centrifugation, hemolysis, and dilution. Compared with the HPLC method, which can be said to be automated, the fact that pretreatment is required for the immunological method remains the same.
For example, even if the whole blood sample is diluted and hemolyzed without diluting hemolysis of the centrifuged blood, in the measurement of HbA1c, the hemoglobin in the erythrocytes is the measurement object and exists in the erythrocytes. If it is erected, the red blood cells will settle, so that it will not be possible to collect the settled red blood cells when sampling from the liquid surface like a serum sample

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for immunologically assaying hemoglobin A1c in specimen
  • Method for immunologically assaying hemoglobin A1c in specimen
  • Method for immunologically assaying hemoglobin A1c in specimen

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0063] Hereinafter, based on an Example, this invention is demonstrated more concretely. However, the present invention is not limited by the following examples.

[0064] 1. Confirmation of buffer-induced hemolysis

[0065] In the measurement system of whole blood samples without pretreatment, it is necessary to add whole blood to the latex reagent (low osmotic pressure buffer containing latex particles) to complete the hemolysis of red blood cells and the adsorption of hemoglobin on the latex surface. Therefore, first, it was confirmed whether the buffer solution itself that allows the latex to float has the effect of hemolyzing erythrocytes.

[0066] 2 mL of the solutions shown in Table 1 were collected into test tubes, 10 μL of whole blood was added thereto, and hemolysis was visually determined. 0.15M NaCl was added to the study as a solution that did not cause hemolysis.

[0067]

[0068] Even in the sample diluent contained in a commercially available kit, hemolysi...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Means that enables an immunoassay of hemoglobin A1c in a whole blood sample without pretreatment of the sample is disclosed. The immunoassay of hemoglobin A1c in a sample according to the present invention comprises bringing latex particles into contact with a non-pretreated whole blood sample in a hypotonic solution, and then bringing hemoglobin A1c adsorbed on the latex particles into contact with an anti-hemoglobin A1c antibody. The immunoassay is preferably carried out by an agglutination method. The hypotonic solution is, for example, a buffer containing a Good's buffer at a concentration of 0.02 to 0.2 mol / L, which Good's buffer has the maximum buffer capacity in the neutral to alkaline region.

Description

technical field [0001] The present invention relates to an immunoassay method for hemoglobin A1c in a sample. Background technique [0002] Hemoglobin A1c (HbA1c) is a hemoglobin (Hb) with a heterotetramer structure consisting of 2 α chains and 2 β chains, in which the α amino group of the N-terminal valine of the β chain is a non-enzymatic sugar sylated glycated hemoglobin. The blood level of this HbA1c reflects the long-term blood sugar control state of diabetes. Therefore, the measurement of HbA1c is clinically significant in order to know the state of blood sugar control, and the measurement of HbA1c is performed for monitoring the therapeutic effect of diabetes and the like. Afterwards, the diagnostic criteria for diabetes were revised from July 2010, and it was found that the HbA1c value has a certain relationship with the onset of retinopathy, so HbA1c above 6.1% (JDS value) was added to the criteria for diabetes (non-diabetic). Patent Document 1). Furthermore, si...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): G01N33/53G01N33/48G01N33/545
CPCG01N33/5306G01N33/721G01N33/54313G01N33/54393G01N33/723
Inventor 铁本融平田稔
Owner FUJIREBIO CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products